Transjugular closure of a large patent ductus arteriosus in a 1100-g infant.

The patent ductus arteriosus is the most common cardiac anomaly in neonates. Haemodynamically significant patent ductus arteriosus is associated with increased morbidity and mortality in preterm babies. Transfemoral venous access is the standard route for patent ductus arteriosus device closure, even in very low birth weight infants. The transjugular approach is also an alternative, but it is more challenging, especially in preterm infants. We report a successful transjugular closure of a patent ductus arteriosus in a 1100‑g infant (the smallest worldwide), where transfemoral access was not possible due to bilateral iliofemoral venous thrombosis.